[ad_1]
The timing of the agency’s expected action on the donanemab drug would be postponed beyond the first quarter, the company said.
[ad_2]
#Eli #Lilly #Alzheimer039s #Drug #Delayed #FDA #Plans #Advisory #Panel #Meeting
News for All
[ad_1]
The timing of the agency’s expected action on the donanemab drug would be postponed beyond the first quarter, the company said.
[ad_2]
#Eli #Lilly #Alzheimer039s #Drug #Delayed #FDA #Plans #Advisory #Panel #Meeting